If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

VRDN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.48%

Insider Buying (Last 12 Months): $10,160,303.50

Insider Selling (Last 12 Months): $7,720,744.70

Viridian Therapeutics Insider Trading History Chart

Viridian Therapeutics Share Price & Price History

^$26.72

▼ -1.32 (-4.71%)

As of 03/21/2023 05:00 PM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Viridian Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/13/2023	Scott Dunseth Myers	CEO	Buy	5,500	$29.15	$160,325.00	255,500
3/9/2023	Lara Meisner	General Counsel	Sell	29,971	$29.07	$871,256.97
2/2/2023	Jonathan Violin	Insider	Sell	50,000	$36.80	$1,840,000.00	430,905
1/23/2023	Lara Meisner	General Counsel	Sell	6,843	$35.66	$244,021.38
1/17/2023	Barrett Katz	insider	Sell	24,853	$37.21	$924,780.13
1/13/2023	Barrett Katz	insider	Sell	4,147	$37.01	$153,480.47
1/10/2023	Barrett Katz	insider	Sell	47,377	$35.30	$1,672,408.10
12/20/2022	Lara Meisner	General Counsel	Sell	600	$28.07	$16,842.00
12/16/2022	Lara Meisner	General Counsel	Sell	1,297	$28.44	$36,886.68
12/14/2022	Lara Meisner	General Counsel	Sell	15,656	$28.12	$440,246.72
12/12/2022	Lara Meisner	General Counsel	Sell	600	$28.05	$16,830.00
11/15/2022	Lara Meisner	General Counsel	Sell	8,125	$22.05	$179,156.25
8/17/2022	Fairmount Funds Management Llc	Director	Buy	425,531	$23.50	$9,999,978.50	1,363,764
6/1/2022	Jonathan Violin	Insider	Sell	30,000	$12.20	$366,000.00	480,905
5/2/2022	Jonathan Violin	CEO	Sell	30,000	$13.04	$391,200.00	510,905
4/4/2022	Jonathan Violin	Insider	Sell	3,600	$18.93	$68,148.00	540,905
4/1/2022	Jonathan Violin	Insider	Sell	26,400	$18.92	$499,488.00	540,905
2/3/2022	Jonathan Violin	Insider	Sell	909	$19.16	$17,416.44
2/1/2022	Jonathan Violin	Insider	Sell	16,751	$19.55	$327,482.05
9/23/2021	Life Sciences Public F Frazier	Major Shareholder	Buy	200,000	$11.00	$2,200,000.00
9/21/2021	Fairmount Funds Management Llc	Director	Buy	909,000	$11.00	$9,999,000.00

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Viridian Therapeutics (NASDAQ:VRDN)

Institutional Buying and Selling by Quarter

Viridian Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/28/2023	Voya Investment Management LLC	14,297	$0.42M	0.0%	+37.2%	0.050%
2/16/2023	Alliancebernstein L.P.	923,833	$26.99M	0.0%	N/A	3.246%
2/16/2023	Chartwell Investment Partners LLC	61,052	$1.78M	0.1%	+6.1%	0.215%
2/15/2023	Metropolitan Life Insurance Co NY	2,340	$68K	0.0%	+47.0%	0.008%
2/15/2023	MetLife Investment Management LLC	19,843	$0.58M	0.0%	+44.7%	0.070%
2/15/2023	Silverarc Capital Management LLC	3,000	$88K	0.0%	N/A	0.011%
2/15/2023	State of Wisconsin Investment Board	30,032	$0.88M	0.0%	+63.9%	0.106%
2/15/2023	Susquehanna Fundamental Investments LLC	22,777	$0.67M	0.0%	+12.6%	0.080%
2/15/2023	Schonfeld Strategic Advisors LLC	31,400	$0.92M	0.0%	-40.3%	0.110%
2/15/2023	Squarepoint Ops LLC	17,207	$0.50M	0.0%	N/A	0.060%
2/15/2023	Tang Capital Management LLC	692,925	$20.24M	2.9%	-21.5%	2.435%
2/15/2023	Legal & General Group Plc	12,153	$0.36M	0.0%	+19.1%	0.043%
2/15/2023	Morgan Stanley	335,302	$9.79M	0.0%	+103.5%	1.178%
2/15/2023	Norges Bank	134,200	$3.92M	0.0%	N/A	0.472%
2/15/2023	EAM Global Investors LLC	151,906	$4.44M	1.1%	+92.7%	0.534%
2/15/2023	EAM Investors LLC	99,640	$2.91M	0.6%	+85.5%	0.350%
2/15/2023	Fred Alger Management LLC	428,273	$12.51M	0.1%	+64.0%	1.505%
2/15/2023	Algert Global LLC	65,253	$1.91M	0.1%	N/A	0.229%
2/15/2023	AQR Capital Management LLC	7,403	$0.22M	0.0%	N/A	0.026%
2/15/2023	Braidwell LP	313,403	$9.16M	0.3%	N/A	1.101%
2/14/2023	Point72 Asset Management L.P.	260,091	$7.60M	0.0%	-9.3%	0.914%
2/14/2023	VR Adviser LLC	2,699,865	$78.86M	12.7%	+26.7%	9.487%
2/14/2023	Price T Rowe Associates Inc. MD	24,894	$0.73M	0.0%	+41.8%	0.087%
2/14/2023	Moore Capital Management LP	140,000	$4.09M	0.1%	N/A	0.492%
2/14/2023	Marshall Wace LLP	611,457	$17.86M	0.0%	+0.5%	2.148%
2/14/2023	Pura Vida Investments LLC	35,003	$1.02M	0.1%	-53.3%	0.123%
2/14/2023	Engineers Gate Manager LP	8,136	$0.24M	0.0%	N/A	0.029%
2/14/2023	Driehaus Capital Management LLC	444,332	$12.98M	0.2%	+31.9%	1.561%
2/13/2023	Gyon Technologies Capital Management LP	8,086	$0.24M	0.1%	-18.3%	0.028%
2/13/2023	Charles Schwab Investment Management Inc.	102,240	$2.99M	0.0%	+39.0%	0.359%
2/13/2023	Deutsche Bank AG	17,086	$0.50M	0.0%	+54.2%	0.060%
2/13/2023	Vivo Capital LLC	1,678,207	$49.02M	5.6%	+1.1%	5.897%
2/13/2023	Barclays PLC	99,320	$2.90M	0.0%	-84.8%	0.349%
2/13/2023	The Manufacturers Life Insurance Company	14,428	$0.42M	0.0%	+35.6%	0.051%
2/13/2023	ExodusPoint Capital Management LP	190,654	$5.57M	0.1%	+75.0%	0.670%
2/13/2023	Credit Suisse AG	24,044	$0.70M	0.0%	-3.8%	0.084%
2/13/2023	Geode Capital Management LLC	710,985	$20.77M	0.0%	+18.5%	2.498%
2/13/2023	JPMorgan Chase & Co.	172,359	$5.03M	0.0%	+148.9%	0.606%
2/13/2023	Teacher Retirement System of Texas	8,862	$0.26M	0.0%	N/A	0.031%
2/10/2023	Bank of America Corp DE	115,378	$3.37M	0.0%	+103.5%	0.405%
2/10/2023	American International Group Inc.	17,890	$0.52M	0.0%	+42.1%	0.063%
2/10/2023	Amalgamated Bank	5,874	$0.17M	0.0%	+48.1%	0.021%
2/10/2023	Sei Investments Co.	18,936	$0.55M	0.0%	N/A	0.067%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	131,539	$3.84M	0.0%	N/A	0.462%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	16,468	$0.48M	0.0%	+55.2%	0.058%
2/9/2023	Principal Financial Group Inc.	10,129	$0.30M	0.0%	N/A	0.036%
2/9/2023	Citigroup Inc.	57,355	$1.68M	0.0%	+7.5%	0.202%
2/8/2023	UBS Group AG	145,778	$4.26M	0.0%	+195.7%	0.512%
2/8/2023	Swiss National Bank	72,200	$2.11M	0.0%	+7.1%	0.254%
2/8/2023	Russell Investments Group Ltd.	85,127	$2.49M	0.0%	+90.0%	0.299%
2/8/2023	Arizona State Retirement System	8,443	$0.25M	0.0%	N/A	0.030%
2/7/2023	State Board of Administration of Florida Retirement System	9,580	$0.28M	0.0%	-13.2%	0.034%
2/2/2023	SG Americas Securities LLC	6,569	$0.19M	0.0%	-20.7%	0.023%
1/30/2023	New York State Common Retirement Fund	22,820	$0.67M	0.0%	+26.7%	0.080%
1/24/2023	Moody Aldrich Partners LLC	58,911	$1.72M	0.3%	N/A	0.207%
12/8/2022	Bank of New York Mellon Corp	90,263	$1.85M	0.0%	+30.3%	0.317%
11/21/2022	California State Teachers Retirement System	35,052	$0.72M	0.0%	+43.5%	0.123%
11/16/2022	Balyasny Asset Management LLC	169,529	$3.48M	0.0%	N/A	0.596%
11/16/2022	Fred Alger Management LLC	261,083	$5.36M	0.0%	N/A	0.917%
11/16/2022	BNP Paribas Arbitrage SNC	35,445	$0.73M	0.0%	N/A	0.125%
11/15/2022	State Street Corp	1,178,549	$24.17M	0.0%	+159.0%	4.140%
11/15/2022	Tang Capital Management LLC	882,925	$18.11M	2.2%	+120.7%	3.102%
11/15/2022	TCG Crossover Management LLC	1,164,000	$23.87M	7.2%	-11.4%	4.089%
11/15/2022	Vanguard Group Inc.	1,856,800	$38.08M	0.0%	+31.6%	6.523%
11/15/2022	Perceptive Advisors LLC	1,220,575	$25.03M	0.7%	+25.6%	4.288%
11/15/2022	Price T Rowe Associates Inc. MD	17,554	$0.36M	0.0%	N/A	0.062%
11/15/2022	Pura Vida Investments LLC	75,003	$1.54M	0.1%	-28.9%	0.264%
11/15/2022	Parkman Healthcare Partners LLC	35,358	$0.73M	0.2%	N/A	0.124%
11/15/2022	Polar Asset Management Partners Inc.	310,800	$6.38M	0.1%	+420.6%	1.092%
11/15/2022	Kynam Capital Management LP	1,000,000	$20.51M	4.3%	+69.5%	3.514%
11/15/2022	Logos Global Management LP	1,000,000	$20.51M	2.5%	N/A	3.514%
11/15/2022	Marshall Wace LLP	608,662	$12.48M	0.0%	+36.8%	2.139%
11/15/2022	Ensign Peak Advisors Inc	95,775	$1.96M	0.0%	+347.4%	0.337%
11/15/2022	BVF Inc. IL	1,741,840	$35.73M	1.5%	-0.1%	6.120%
11/15/2022	Bank of New York Mellon Corp	90,263	$1.85M	0.0%	+30.3%	0.317%
11/15/2022	Bellevue Group AG	46,100	$0.95M	0.0%	-5.9%	0.162%
11/15/2022	BlackRock Inc.	1,982,062	$40.65M	0.0%	+39.3%	6.964%
11/15/2022	Commodore Capital LP	2,696,340	$55.30M	8.9%	+64.6%	9.474%
11/14/2022	Seven Grand Managers LLC	25,000	$0.51M	1.7%	N/A	0.088%
11/14/2022	LMR Partners LLP	40,787	$0.84M	0.0%	-49.3%	0.143%
11/14/2022	Cormorant Asset Management LP	1,310,000	$26.87M	1.9%	+49.3%	4.602%
11/14/2022	Vivo Capital LLC	1,660,019	$34.05M	3.8%	+27.7%	5.832%
11/14/2022	Point72 Asset Management L.P.	286,707	$5.88M	0.0%	-63.7%	1.007%
11/14/2022	Renaissance Technologies LLC	101,600	$2.08M	0.0%	N/A	0.357%
11/14/2022	RA Capital Management L.P.	880,000	$18.05M	0.4%	N/A	3.092%
11/14/2022	Nuveen Asset Management LLC	102,749	$2.05M	0.0%	+74.4%	0.361%
11/14/2022	VR Adviser LLC	2,130,308	$43.69M	6.4%	+15.0%	7.484%
11/14/2022	UBS Oconnor LLC	81,870	$1.68M	0.0%	+138.1%	0.288%
11/14/2022	Ghost Tree Capital LLC	535,000	$10.97M	3.1%	-10.8%	1.880%
11/10/2022	Credit Suisse AG	24,981	$0.51M	0.0%	+40.5%	0.088%
11/10/2022	ExodusPoint Capital Management LP	108,968	$2.24M	0.0%	N/A	0.383%
11/10/2022	Tower Research Capital LLC TRC	8,173	$0.17M	0.0%	+189.0%	0.029%
11/10/2022	UBS Group AG	49,297	$1.01M	0.0%	+379,107.7%	0.173%
11/9/2022	Zurcher Kantonalbank Zurich Cantonalbank	3,759	$77K	0.0%	N/A	0.013%
11/9/2022	Fairmount Funds Management LLC	1,369,623	$28.09M	4.9%	+45.1%	4.812%
11/8/2022	AlphaCentric Advisors LLC	35,500	$0.73M	0.7%	N/A	0.125%
11/7/2022	Jump Financial LLC	37,015	$0.76M	0.0%	+39.0%	0.130%
11/4/2022	Russell Investments Group Ltd.	44,799	$0.92M	0.0%	N/A	0.157%
11/3/2022	Barclays PLC	653,751	$13.41M	0.0%	+3,473.4%	2.297%
10/31/2022	SG Americas Securities LLC	8,282	$0.17M	0.0%	N/A	0.029%

Data available starting January 2016

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Today's Range

Now: $26.72

$26.70

$28.48

50 Day Range

MA: $33.63

$27.45

$37.60

52 Week Range

Now: $26.72

$9.47

$39.00

Volume

349,728 shs

Average Volume

594,386 shs

Market Capitalization

$1.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95

Who are the company insiders with the largest holdings of Viridian Therapeutics?: Viridian Therapeutics' top insider investors include:
Fairmount Funds Management Llc (Director)
Jonathan Violin (Insider)
Jonathan Violin (CEO)
Scott Dunseth Myers (CEO)
Barrett Katz (Insider)
Lara Meisner (General Counsel)
Life Sciences Public F Frazier (Major Shareholder)
Learn More about top insider investors at Viridian Therapeutics.
Who are the major institutional investors of Viridian Therapeutics?: Viridian Therapeutics' top institutional shareholders include:
VR Adviser LLC — 9.49%
Vivo Capital LLC — 5.90%
Alliancebernstein L.P. — 3.25%
Geode Capital Management LLC — 2.50%
Tang Capital Management LLC — 2.43%
Marshall Wace LLP — 2.15%
Learn More about top institutional investors of Viridian Therapeutics stock.
Which major investors are selling Viridian Therapeutics stock?: During the last quarter, VRDN stock was sold by these institutional investors:
Barclays PLC
Tang Capital Management LLC
Pura Vida Investments LLC
Point72 Asset Management L.P.
Schonfeld Strategic Advisors LLC
Gyon Technologies Capital Management LP
SG Americas Securities LLC
State Board of Administration of Florida Retirement System
Within the previous year, company insiders that have sold Viridian Therapeutics company stock include:
Fairmount Funds Management Llc (Director)
Jonathan Violin (Insider)
Jonathan Violin (CEO)
Scott Dunseth Myers (CEO)
Learn More investors selling Viridian Therapeutics stock.
Which major investors are buying Viridian Therapeutics stock?: In the previous quarter, VRDN stock was purchased by institutional investors including:
Alliancebernstein L.P.
VR Adviser LLC
Braidwell LP
Morgan Stanley
Fred Alger Management LLC
Moore Capital Management LP
Norges Bank
Connor Clark & Lunn Investment Management Ltd.
Within the last year, these company insiders have bought Viridian Therapeutics stock:
Fairmount Funds Management Llc (Director)
Jonathan Violin (Insider)
Jonathan Violin (CEO)
Learn More investors buying Viridian Therapeutics stock.